Cargando…
TP53I11 suppresses epithelial-mesenchymal transition and metastasis of breast cancer cells
Epithelial-mesenchymal transition (EMT) is widely-considered to be a modulating factor of anoikis and cancer metastasis. We found that, in MDA-MB-231 cells, TP53I11 (tumor protein P53 inducible protein 11) suppressed EMT and migration in vitro, and inhibited metastasis in vivo. Our findings showed t...
Autores principales: | Xiao, Tongqian, Xu, Zhongjuan, Zhang, Hai, Geng, Junsa, Qiao, Yong, Liang, Yu, Yu, Yanzhen, Dong, Qun, Suo, Guangli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605526/ https://www.ncbi.nlm.nih.gov/pubmed/30940320 http://dx.doi.org/10.5483/BMBRep.2019.52.6.173 |
Ejemplares similares
-
TP53 Mutation, Epithelial-Mesenchymal Transition, and Stemlike Features in Breast Cancer Subtypes
por: Coradini, Danila, et al.
Publicado: (2012) -
The Extracellular Matrix Enriched With Exosomes for the Treatment on Pulmonary Fibrosis in Mice
por: Yu, Yanzhen, et al.
Publicado: (2021) -
TP53INP2 Contributes to TGF-β2-Induced Autophagy during the Epithelial–Mesenchymal Transition in Posterior Capsular Opacification Development
por: Cui, Yilei, et al.
Publicado: (2022) -
Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells
por: Wang, Zheng, et al.
Publicado: (2013) -
Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)